Oncology and hematology

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• Protein tyrosine kinase (PTK)-encoding oncogenes and ras are frequently overexpressed or altered in various cancers.
• These genetic alterations are key drivers in the development of epithelial and lymphohematopoietic malignancies.
• Signal transduction pathways involving ras proteins play a crucial role in cell growth and proliferation.

Purpose of the Study:

• To highlight the significance of PTK-encoding oncogenes and ras in cancer development.
• To identify ras-based pathways as a potential molecular target for therapeutic intervention.
• To explore the implications of targeting these pathways for cancer prevention.

Main Methods:

• Review of existing literature on oncogene and ras pathway dysregulation in cancer.
• Analysis of the role of signal transduction in malignant neoplasm evolution.
• Identification of therapeutic strategies targeting molecular pathways.

Main Results:

• Net overexpression or derangements of PTK-encoding oncogenes and ras are critical drivers in numerous cancers.
• Ras-based signaling pathways are implicated in the progression of both epithelial and lymphohematopoietic cancers.
• The study underscores the oncogenic potential of these molecular alterations.

Conclusions:

• Impeding signal transduction through ras-based pathways presents a promising molecular target.
• Targeting ras pathways could offer a broad therapeutic strategy for various cancers.
• This approach holds potential for both cancer therapy and prevention.